Molecular imaging demonstrates promise for predicting complete pathologic response in HER2-positive breast cancer

Дата публикации: 16-10-2026 19:40:08

Molecular imaging with ⁶⁸Ga-HER2 PET/CT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New PET imaging approach detects almost all lesions in common form of kidney cancer	0	7.93	20-10-2026
2	Anti-Müllerian hormone predicts benefit of chemo + endocrine therapy in under-55s with breast cancer	0	12.26	12-08-2026
3	New MRI contrast agent detects invasive lung cancer earlier	0	10	16-09-2026
4	Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer	0	10.24	01-07-2026
5	Enhertu превзошел стандартную первую линию терапии при HER2-мутантном раке легкого в исследовании III фазы	0	17.14	18-08-2026
6	‘Liquid biopsy’ tech contributes to successful clinical trial for detecting breast cancer recurrence	0	6.61	29-07-2020
7	В России разработали тест для оценки агрессивности рака молочной железы	5	7	01-07-2026
8	Next-generation total-body PET scanner can produce diagnostic-quality images in as little as 1 minute	0	13.95	18-10-2026
9	Disparities in breast cancer mortality between rural and urban patients projected to widen by 2035	0	10.12	19-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 10.96. Источник: medicalxpress.com.